IRIS Accounts Production v23.3.1.45 09838346 Board of Directors 1.1.22 31.12.22 31.12.22 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure098383462021-12-31098383462022-12-31098383462022-01-012022-12-31098383462021-09-30098383462021-10-012021-12-31098383462021-12-3109838346ns16:EnglandWales2022-01-012022-12-3109838346ns15:PoundSterling2022-01-012022-12-3109838346ns11:Director12022-01-012022-12-3109838346ns11:PrivateLimitedCompanyLtd2022-01-012022-12-3109838346ns11:SmallEntities2022-01-012022-12-3109838346ns11:AuditExempt-NoAccountantsReport2022-01-012022-12-3109838346ns11:SmallCompaniesRegimeForDirectorsReport2022-01-012022-12-3109838346ns11:SmallCompaniesRegimeForAccounts2022-01-012022-12-3109838346ns11:FullAccounts2022-01-012022-12-310983834612022-01-012022-12-3109838346ns11:Director22022-01-012022-12-3109838346ns11:Director32022-01-012022-12-3109838346ns11:Director42022-01-012022-12-3109838346ns11:CompanySecretary12022-01-012022-12-3109838346ns11:RegisteredOffice2022-01-012022-12-3109838346ns6:CurrentFinancialInstruments2022-12-3109838346ns6:CurrentFinancialInstruments2021-12-3109838346ns6:Non-currentFinancialInstruments2022-12-3109838346ns6:Non-currentFinancialInstruments2021-12-3109838346ns6:ShareCapital2022-12-3109838346ns6:ShareCapital2021-12-3109838346ns6:SharePremium2022-12-3109838346ns6:SharePremium2021-12-3109838346ns6:RetainedEarningsAccumulatedLosses2022-12-3109838346ns6:RetainedEarningsAccumulatedLosses2021-12-3109838346ns6:IntangibleAssetsOtherThanGoodwill2022-01-012022-12-3109838346ns6:PatentsTrademarksLicencesConcessionsSimilar2022-01-012022-12-3109838346ns6:PlantMachinery2022-01-012022-12-3109838346ns6:FurnitureFittings2022-01-012022-12-3109838346ns6:IntangibleAssetsOtherThanGoodwill2021-12-3109838346ns6:IntangibleAssetsOtherThanGoodwill2022-12-3109838346ns6:IntangibleAssetsOtherThanGoodwill2021-12-3109838346ns6:PlantMachinery2021-12-3109838346ns6:FurnitureFittings2021-12-3109838346ns6:MotorVehicles2021-12-3109838346ns6:ComputerEquipment2021-12-3109838346ns6:MotorVehicles2022-01-012022-12-3109838346ns6:ComputerEquipment2022-01-012022-12-3109838346ns6:PlantMachinery2022-12-3109838346ns6:FurnitureFittings2022-12-3109838346ns6:MotorVehicles2022-12-3109838346ns6:ComputerEquipment2022-12-3109838346ns6:PlantMachinery2021-12-3109838346ns6:FurnitureFittings2021-12-3109838346ns6:MotorVehicles2021-12-3109838346ns6:ComputerEquipment2021-12-3109838346ns6:WithinOneYearns6:CurrentFinancialInstruments2022-12-3109838346ns6:WithinOneYearns6:CurrentFinancialInstruments2021-12-31
REGISTERED NUMBER: 09838346 (England and Wales)













Unaudited Financial Statements

for the Year Ended 31 December 2022

for

NTL Biologica Limited

NTL Biologica Limited (Registered number: 09838346)






Contents of the Financial Statements
for the Year Ended 31 December 2022




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


NTL Biologica Limited

Company Information
for the Year Ended 31 December 2022







DIRECTORS: I C Graney
Mrs S J Graney
H M Oh
J A Gripton





SECRETARY: Mrs S J Graney





REGISTERED OFFICE: Boston House
Boston Road
Henley-on-Thames
RG9 1DY





REGISTERED NUMBER: 09838346 (England and Wales)





ACCOUNTANTS: Villars Hayward LLP
Chartered Accountants,
Chartered Tax Advisers and Registered Auditors
Boston House
Henley-on-Thames
RG9 1DY

NTL Biologica Limited (Registered number: 09838346)

Statement of Financial Position
31 December 2022

31.12.22 31.12.21
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 2,901 3,046
Tangible assets 5 91,533 85,294
94,434 88,340

CURRENT ASSETS
Stocks 25,650 78,735
Debtors 6 270,255 318,856
Cash at bank 840 157,882
296,745 555,473
CREDITORS
Amounts falling due within one year 7 624,807 489,779
NET CURRENT (LIABILITIES)/ASSETS (328,062 ) 65,694
TOTAL ASSETS LESS CURRENT LIABILITIES (233,628 ) 154,034

CREDITORS
Amounts falling due after more than one year 8 (31,320 ) (40,486 )

PROVISIONS FOR LIABILITIES (17,213 ) -
NET (LIABILITIES)/ASSETS (282,161 ) 113,548

CAPITAL AND RESERVES
Called up share capital 330,549 330,549
Share premium 577,201 577,201
Retained earnings (1,189,911 ) (794,202 )
(282,161 ) 113,548

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2022.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2022 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

NTL Biologica Limited (Registered number: 09838346)

Statement of Financial Position - continued
31 December 2022


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19 January 2024 and were signed on its behalf by:





I C Graney - Director


NTL Biologica Limited (Registered number: 09838346)

Notes to the Financial Statements
for the Year Ended 31 December 2022

1. STATUTORY INFORMATION

NTL Biologica Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of nil years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance
Fixtures and fittings - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company contributes to the National Employment Savings Trust (NEST) which is a defined contribution scheme.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 8 (2021 - 9 ) .

NTL Biologica Limited (Registered number: 09838346)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2022

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 January 2022
and 31 December 2022 3,626
AMORTISATION
At 1 January 2022 580
Charge for year 145
At 31 December 2022 725
NET BOOK VALUE
At 31 December 2022 2,901
At 31 December 2021 3,046

5. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Office Computer
machinery fittings equipment equipment Totals
£    £    £    £    £   
COST
At 1 January 2022 186,867 36,267 1,860 1,810 226,804
Additions 33,250 - - - 33,250
At 31 December 2022 220,117 36,267 1,860 1,810 260,054
DEPRECIATION
At 1 January 2022 110,449 27,391 1,860 1,810 141,510
Charge for year 24,792 2,219 - - 27,011
At 31 December 2022 135,241 29,610 1,860 1,810 168,521
NET BOOK VALUE
At 31 December 2022 84,876 6,657 - - 91,533
At 31 December 2021 76,418 8,876 - - 85,294

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.22 31.12.21
£    £   
Trade debtors 58,653 140,964
Other debtors 211,602 177,892
270,255 318,856

NTL Biologica Limited (Registered number: 09838346)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2022

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.22 31.12.21
£    £   
Bank loans and overdrafts 33,576 9,167
Trade creditors 23,773 16,042
Taxation and social security 60,798 13,163
Other creditors 506,660 451,407
624,807 489,779

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
31.12.22 31.12.21
£    £   
Bank loans 31,320 40,486

Amounts falling due in more than five years:

Repayable by instalments
Bounce back loan more 5 yr by instal - 3,819